POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,279,520 | +37.7% | 2,638,454 | +1.8% | 0.00% | – |
| Q2 2023 | $4,560,510 | -37.3% | 2,591,199 | +9.8% | 0.00% | – |
| Q1 2023 | $7,271,116 | -41.2% | 2,360,752 | +1.3% | 0.00% | – |
| Q4 2022 | $12,355,922 | +46.8% | 2,331,306 | -2.2% | 0.00% | – |
| Q3 2022 | $8,419,000 | +146.2% | 2,384,866 | +79.9% | 0.00% | – |
| Q2 2022 | $3,420,000 | -47.2% | 1,325,650 | -8.3% | 0.00% | – |
| Q1 2022 | $6,479,000 | -34.5% | 1,446,264 | -0.4% | 0.00% | – |
| Q4 2021 | $9,889,000 | -10.5% | 1,452,155 | -4.2% | 0.00% | – |
| Q3 2021 | $11,046,000 | -17.1% | 1,515,194 | +13.9% | 0.00% | – |
| Q2 2021 | $13,331,000 | -2.9% | 1,330,451 | -7.4% | 0.00% | – |
| Q1 2021 | $13,727,000 | +112.8% | 1,437,334 | +144.4% | 0.00% | – |
| Q4 2020 | $6,452,000 | +28.3% | 588,089 | +3.7% | 0.00% | – |
| Q3 2020 | $5,030,000 | – | 566,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |